State Of Wisconsin Investment Board Chinook Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$18.66 - $38.58 $233,212 - $482,172	12,498 Added 33.84%	49,436 $1.9 Million
Q1 2023 May 15, 2023	SELL	$21.53 - $26.8 $87,411 - $108,808	-4,060 Reduced 9.9%	36,938 $855,000
Q4 2022 Feb 14, 2023	BUY	$18.63 - $27.35 $16,617 - $24,396	892 Added 2.22%	40,998 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$17.51 - $23.37 $38,031 - $50,759	-2,172 Reduced 5.14%	40,106 $788,000
Q2 2022 Aug 15, 2022	BUY	$12.59 - $18.8 $19,867 - $29,666	1,578 Added 3.88%	42,278 $739,000
Q3 2021 Nov 12, 2021	BUY	$11.5 - $14.86 $89,424 - $115,551	7,776 Added 23.62%	40,700 $519,000
Q2 2021 Aug 12, 2021	BUY	$13.6 - $18.98 $204,326 - $285,155	15,024 Added 83.93%	32,924 $465,000
Q1 2021 May 17, 2021	SELL	$14.17 - $19.11 $9,919 - $13,377	-700 Reduced 3.76%	17,900 $278,000
Q4 2020 Feb 03, 2021	BUY	$11.9 - $20.91 $221,340 - $388,926	18,600 New	18,600 $295,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.